Ricardo Grieshaber-bouyer MD

Dr. Ricardo Grieshaber-Bouyer is a Professor of Clinical Systems Immunology and Head of the Clinical Trial Unit. He leads a dynamic clinical and translational research team. His team has pioneered the first-in-patient applications of T-cell redirecting therapies for autoimmune diseases, with seminal studies published in the New England Journal of Medicine and Nature Medicine. He serves as a Global Principal Investigator for innovative, early-phase trials and manages a portfolio of cutting-edge immunology studies focused on precision cell depletion.

Academically, he led a 15-member research group that works on developing new precision cell-depleting therapies and understanding immunological hallmarks of therapy response and relapse. This research program is supported by nearly $10 million in secured PI funding. Bridging academia and industry, he leverages his dual background in medicine and business to drive the development of innovative therapeutics by serving on Scientific Advisory Boards and advising on preclinical benchmarking, asset acquisition, and clinical strategy.